NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125C959. A total of 4 filers reported holding NEUROCRINE BIOSCIENCES INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $1,413,000 | -39.5% | 31,100 | -47.4% | 0.00% | -33.3% |
| Q1 2016 | $2,337,000 | -52.2% | 59,100 | -31.7% | 0.00% | -40.0% |
| Q4 2015 | $4,893,000 | +66.0% | 86,500 | +16.7% | 0.01% | +66.7% |
| Q3 2015 | $2,948,000 | +69.1% | 74,100 | +103.0% | 0.00% | +50.0% |
| Q2 2015 | $1,743,000 | +16.7% | 36,500 | -2.9% | 0.00% | +100.0% |
| Q1 2015 | $1,493,000 | +70.0% | 37,600 | -4.3% | 0.00% | 0.0% |
| Q4 2014 | $878,000 | +119.5% | 39,300 | +54.1% | 0.00% | – |
| Q3 2014 | $400,000 | +48.1% | 25,500 | +40.1% | 0.00% | – |
| Q2 2014 | $270,000 | +22.2% | 18,200 | +32.8% | 0.00% | – |
| Q1 2014 | $221,000 | +41.7% | 13,700 | -18.0% | 0.00% | – |
| Q4 2013 | $156,000 | -34.2% | 16,700 | -20.1% | 0.00% | – |
| Q3 2013 | $237,000 | -38.1% | 20,900 | -26.9% | 0.00% | -100.0% |
| Q2 2013 | $383,000 | – | 28,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JANE STREET GROUP, LLC | 185,700 | $18,102,000 | 0.01% |
| GROUP ONE TRADING, L.P. | 38,200 | $3,724,000 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| SIMPLEX TRADING, LLC | 1,400 | $136,000 | 0.00% |